Oncogenesis

Journal

Overview
Identity

Publication Venue For

Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors. 10. 2021

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis. 10. 2021

Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors. 10. 2021

LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1. 9. 2020

Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R. 9. 2020

PRMT1 promotes neuroblastoma cell survival through ATF5. 9. 2020

Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation. 8. 2019

Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins.. 5:e202. 2016

Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. 4. 2015

COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP.. 1:e5. 2012

International Standard Serial Number (issn)

2157-9024

Electronic International Standard Serial Number (eissn)

2157-9024